The International Cannabis Business Conference (ICBC) Berlin is one of the most important specialist events in the cannabis industry worldwide and is the most important platform of its kind in Europe. Every year, it brings together leading players from politics, business, medicine and research in Berlin to discuss the latest developments in medical cannabis, regulation and market opportunities.
The ICBC Berlin offers:
Top speakers from the international cannabis industry
Insights into regulatory developments, especially in Europe
Networking at the highest level with investors, producers, pharmacies and service providers
Exhibition of innovative products and services
The event is becoming increasingly important, especially in the wake of increasing liberalization in Germany and Europe. It serves as an interface between legislation, the market and medical applications
Sainfort Pharma AG will also be represented at ICBC Berlin, a clear signal of its ambitions in the European market.
Sainfort Pharma AG was founded with the aim of further advancing the supply of high-quality medicinal cannabis flowers. In doing so, the company consistently focuses on pharmaceutical standards, quality assurance and sustainable partnerships in the healthcare sector.
A central focus is on:
Direct distribution to pharmacies to make supply chains more efficient and transparent
Access to high-quality cannabis products for medical applications
Building a strong network within the European cannabis industry
Leonard Metsch, Business Development Manager & Sales at Sainfort Pharma AG, will be there in person.
He will be available for discussions, partnerships and specific business approaches.
Contact details:
Phone: +41 77 463 75 80
Email: leonard.metsch@sainfortpharma.ch
LinkedIn: https://www.linkedin.com/in/leonard-metsch-545b741b/
The presence of Sainfort Pharma AG underlines the company's role as an ambitious player in the field of medical cannabis. This is an ideal opportunity for pharmacies, partners and investors to establish contacts at an early stage and tap into joint growth opportunities.